Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease

Conclusion: Analysis of data obtained show high efficacy and safety of Valsartan in the treatment of AH level I-II in patients with COPD.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Calancea, V., Ghicavii, N., Cretu, A., Antonova, N., Oprea, S., Matcovschi, S. Tags: Airway pharmacology and treatment Source Type: research